Robert Nelsen
InvestorAdvisor at Time BioVentures
About
Robert Nelsen is a co-founder and Managing Director of ARCH Venture Partners, where he has been involved in the creation, early sourcing, financing, and development of more than 150 companies. He focuses on early-stage investing in novel platform technologies aimed at improving health care and outcomes. He holds an M.B.A. from the University of Chicago and a B.S. in Economics and Biology from the University of Puget Sound.
Invests in
BiotechDigital HealthHealthtech
Investments
Board seats
Brii BiosciencesDenali TherapeuticsHua MedicineInsitroMaze TherapeuticsNational ResilienceNeumora TherapeuticsNutcracker TherapeuticsPrime MedicineSana BiotechnologyVir Biotechnology
Investor
Alnylam PharmaceuticalsAltos LabsArray BioPharmaBeam TherapeuticsEQRxIlluminaJuno TherapeuticsKaruna TherapeuticsLyell Immunopharma
Per the firm's website.
Colleagues at Time BioVentures
Frequently asked questions
- Who is Robert Nelsen?
- Robert Nelsen is a co-founder and Managing Director of ARCH Venture Partners, where he has been involved in the creation, early sourcing, financing, and development of more than 150 companies. He focuses on early-stage investing in novel platform technologies aimed at improving health care and outcomes. He holds an M.B.A. from the University of Chicago and a B.S. in Economics and Biology from the University of Puget Sound.
- Where does Robert Nelsen work?
- Robert Nelsen is Advisor at Time BioVentures.
- What does Robert Nelsen invest in?
- Robert Nelsen invests in Biotech, Digital Health, Healthtech.
- What boards does Robert Nelsen sit on?
- Robert Nelsen holds tracked board seats at Brii Biosciences, Denali Therapeutics, Hua Medicine, Insitro, Maze Therapeutics, National Resilience, Neumora Therapeutics, Nutcracker Therapeutics, Prime Medicine, Sana Biotechnology.
- What companies has Robert Nelsen invested in?
- Investments tracked here include Alnylam Pharmaceuticals, Altos Labs, Array BioPharma, Beam Therapeutics, EQRx, Illumina, Juno Therapeutics, Karuna Therapeutics, Lyell Immunopharma.
Are you in our directory? β or find your own page and tap it there to see your paths to every investor.